ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Cardiovascular Disease

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

6,319Medicare Part D Prescriptions Filled, Including Refills

Rank: 171 out of 1448

$321K Total Retail Price of All Prescriptions

Rank: 308 out of 1448

455 Patients Receiving at Least One Drug in Part D
85%Patients 65 Years and Older
61% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in California
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

3% of this provider’s 455 patients filled at least one prescription for a schedule three drug, compared to an average of 2%.

Risky Drugs to Seniors

2% of this provider’s 5,459 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 0%.

Brand Name Drugs

21% of this provider’s prescriptions were for brand-name drugs, compared to an average of 28%.

Prescription Price

$51 was the average price of a prescription from this provider, compared to $67 among peers.

Prescriptions per Patient

14 is the average number of prescriptions (including refills) per patient, compared to an average of 12.


This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in California
LISINOPRIL 625 537 1 5
METOPROLOL TARTRATE 424 381 2 9
ATORVASTATIN CALCIUM 311 269 3 4
WARFARIN SODIUM 256 216 4 8
SIMVASTATIN 245 213 5 3
CLOPIDOGREL 232 197 6 10
CARVEDILOL 206 180 7 1
FUROSEMIDE 198 176 8 7
PLAVIX 190 157 9 14
LOSARTAN POTASSIUM 190 171 9 11
AMLODIPINE BESYLATE 177 155 11 2
DIGOXIN 173 162 12 13
ISOSORBIDE MONONITRATE ER 153 120 13 16
LEVOTHYROXINE SODIUM 120 98 14 21
OMEPRAZOLE 119 113 15 23
LOVASTATIN 94 89 16 35
POTASSIUM CHLORIDE 81 75 17 19
ATENOLOL 81 78 17 12
AMIODARONE HCL 75 70 19 22
METFORMIN HCL 71 56 20 25
METOPROLOL SUCCINATE 69 53 21 6
PANTOPRAZOLE SODIUM 69 64 21 42
HYDROCODONE-ACETAMINOPHEN 65 61 S3 23 33
HYDROCHLOROTHIAZIDE 64 58 24 18
NITROSTAT 60 53 25 31
DILTIAZEM 24HR CD 58 46 26 61
LIPITOR 57 44 27 30
FAMOTIDINE 55 28 28 60
KLOR-CON 10 54 53 29 102
LISINOPRIL-HYDROCHLOROTHIAZIDE 53 49 30 79
LOSARTAN-HYDROCHLOROTHIAZIDE 50 50 31 38
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Oct. 31, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.